Last reviewed · How we verify

Aerosolized All trans retinoic acid plus Vitamin D

Kafrelsheikh University · FDA-approved active Small molecule Quality 1/100

Aerosolized All trans retinoic acid plus Vitamin D is a Small molecule drug developed by Kafrelsheikh University. It is currently FDA-approved.

At a glance

Generic nameAerosolized All trans retinoic acid plus Vitamin D
SponsorKafrelsheikh University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Aerosolized All trans retinoic acid plus Vitamin D

What is Aerosolized All trans retinoic acid plus Vitamin D?

Aerosolized All trans retinoic acid plus Vitamin D is a Small molecule drug developed by Kafrelsheikh University.

Who makes Aerosolized All trans retinoic acid plus Vitamin D?

Aerosolized All trans retinoic acid plus Vitamin D is developed and marketed by Kafrelsheikh University (see full Kafrelsheikh University pipeline at /company/kafrelsheikh-university).

What development phase is Aerosolized All trans retinoic acid plus Vitamin D in?

Aerosolized All trans retinoic acid plus Vitamin D is FDA-approved (marketed).

Related